SCHEMBL7474444

SCHEMBL7474444

CCCc1cc2ccc(C(=O)OC)cc2n1C(C)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
APOBEC3A P31941 2/20 0.42
APOBEC3G Q9HC16 2/20 0.42
POLB P06746 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40
TSHR P16473 1/20 0.40
LCK P06239 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7463828 0.90 KDM4E (0.45) KDM4ESMN1; SMN2ALDH1A1HPGDAPOBEC3A
SCHEMBL7422778 0.87 KDM4E (0.40) KDM4ESMN1; SMN2ALDH1A1HPGDAPOBEC3A
SCHEMBL7421832 0.85 KDM4E (0.42) KDM4ESMN1; SMN2ALDH1A1HPGDAPOBEC3A
SCHEMBL7423925 0.81 APOBEC3A (0.44) KDM4ESMN1; SMN2ALDH1A1HPGDAPOBEC3A
SCHEMBL17680280 0.75 MTNR1A (0.46) KDM4ESMN1; SMN2ALDH1A1HPGDAPOBEC3A
SCHEMBL7422231 0.73 MAPT (0.47) KDM4EALDH1A1HPGDPOLBL3MBTL1
SCHEMBL7418922 0.73 PTGDR2 (0.41) KDM4ESMN1; SMN2ALDH1A1HPGDAPOBEC3A
SCHEMBL7417793 0.70 APOBEC3A (0.45) KDM4ESMN1; SMN2ALDH1A1HPGDAPOBEC3A
SCHEMBL29342927 0.70 KDM4E (0.59) KDM4ESMN1; SMN2ALDH1A1HPGDAPOBEC3A
SCHEMBL28414204 0.69 KDM4E (0.62) KDM4ESMN1; SMN2ALDH1A1HPGDAPOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed